MIRA INFORM REPORT

 

 

Report Date :

23.09.2014

 

IDENTIFICATION DETAILS

 

Name :

SPANSULES PHARMATECH PRIVATE LIMITED

 

 

Registered Office :

Plot No. 59, G-3, Sri Venkateshwara, Towers, Bhagyanagar Colony, Opposite K.P.H.B Hyderabad – 500072, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

09.10.2000

 

 

Com. Reg. No.:

01-035421

 

 

Capital Investment / Paid-up Capital :

Rs.19.756 Millions

 

 

CIN No.:

[Company Identification No.]

U24230AP2000PTC035421

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS04126D

 

 

PAN No.:

[Permanent Account No.]

AAFCS7057K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

No. of Employees :

80 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (32)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 170000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The company possesses an acceptable financial profile marked by adequate net worth base along with modest working capital intensive operations.

 

Management has reported a marginal reduction in the sales turnover due to inconsistence in power supply and hefty competition in the pharmacy market.

 

Further, the net profitability has seen a drastic hit as a result of heavy increase in interest burden during FY13.

 

However, trade relations are fair. Business is active. Payment terms are reported as slow but correct.

 

The subject can be considered for business dealings with some caution.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Guttikonda Venkata Subba

Designation :

Director

Contact No.:

91-9000544189

Date :

23.06.2014

 

 

LOCATIONS

 

Registered Office / Corporate Office :

Plot No. 59, G-3, Sri Venkateshwara Towers, Bhagyanagar Colony, Opposite K.P.H.B Hyderabad – 500072, Andhra Pradesh, India

Tel. No.:

91-40-46679999

Mobile No.:

91-9000544189 (Mr. Guttikonda Venkata Subba)

Fax No.:

91-40-23050443 / 23061979

E-Mail :

info@spansulespharma.com

Website :

http://spansulespharma.com

 

 

Factory:

Plot No.163, Subhash Nagar, IDA, Jeedmetala, Hyderabad – 500055, Andhra Pradesh, India

Tel No.:

91-4023194045

Fax No.:

91-40-23095782

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Guttikonda Venkata Subba Rao

Designation :

Managing Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar Colony, Kukatpally, District Rangareddy, Hyderabad – 500072, Andhra Pradesh, India

Date of Birth/Age :

15.021964

Date of Appointment :

09.10.2000

DIN No.:

01900749

 

 

Name :

Mrs. Guttikonda Rama Devi

Designation :

Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar Colony, Kukatpally, District Rangareddy, Hyderabad - 500072, Andhra Pradesh, India

Date of Birth/Age :

30.03.1971

Date of Appointment :

09.10.2000

DIN No.:

02019526

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Name of Shareholders

No. of Shares

%age

Guttikonda Venkata Subba Rao

1,255,620

63.56

Guttikonda Rama Devi

720,000

36.44

TOTAL

1,975,620

100.00

 

 

AS ON 30.09.2013

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

Products :

Drugs and Medicines 

 

 

GENERAL INFORMATION

 

No. of Employees :

80 (Approximately)

 

 

Bankers :

Canara Bank,  SME Branch, Plot No. 74, Prashanthi Nagar, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2013

Rs. In Millions

31.03.2012

Long Term Borrowings

 

 

Bonds / Debentures

6.565

9.581

Short Term Borrowings

 

 

Loans repayable on demand

32.432

34.595

 

 

 

TOTAL

38.997

44.176

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rao and Siva Associates

Chartered Accountants

Address :

Plot No. 121/7, 19th Road, Vivekannanda Nagar, Colony, Kukat Pally, Hyderabad - 500072, Andhra Pradesh, India

Mobile No.:

9948749499/9491049499

PAN No.:

AGPPM3948Q

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs. 30.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1975620

Equity Shares

Rs.10/- each

Rs. 19.756 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

19.756

10.150

10.150

(b) Reserves & Surplus

22.438

22.278

19.340

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

1.000

11.066

3.947

Total Shareholders’ Funds (1) + (2)

43.194

43.494

33.437

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

6.565

9.581

2.645

(b) Deferred tax liabilities (Net)

1.246

1.132

0.620

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

7.811

10.713

3.265

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

32.432

34.595

15.023

(b) Trade payables

64.665

43.048

31.110

(c) Other current liabilities

0.495

0.494

0.361

(d) Short-term provisions

4.215

3.698

2.322

Total Current Liabilities (4)

101.807

81.835

48.816

 

 

 

 

TOTAL

152.812

136.042

85.518

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

31.171

33.498

26.641

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

8.208

6.001

4.090

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

2.211

1.705

1.382

(e) Other Non-current assets

0.352

0.000

0.000

Total Non-Current Assets

41.942

41.204

32.113

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

30.666

28.654

20.354

(c) Trade receivables

75.173

59.321

30.758

(d) Cash and cash equivalents

1.353

0.119

0.125

(e) Short-term loans and advances

3.678

6.744

2.168

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

110.870

94.838

53.405

 

 

 

 

TOTAL

152.812

136.042

85.518

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

163.464

183.778

83.588

 

Other Income

1.658

0.574

0.077

 

TOTAL (A)

165.122

184.352

83.665

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Material Consumed

115.012

140.965

52.887

 

Employees benefits expense

15.727

14.421

12.590

 

Other expenses

24.581

19.453

11.052

 

TOTAL (B)

155.320

174.839

76.529

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

9.802

9.513

7.136

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

4.820

2.903

1.717

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

4.982

6.610

5.419

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

4.411

2.287

1.573

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

0.571

4.323

3.846

 

 

 

 

 

Less

TAX (I)

0.411

1.385

1.267

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-I)   (J)

0.160

2.938

2.579

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

0.81

14.87

2.54

 

 

KEY RATIOS

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

0.10

1.59

3.08

 

 

 

 

 

Net Profit Margin
(PBT/Sales)

(%)

0.35

5.17

4.60

 

 

 

 

 

Return on Total Assets
(PBT/Total Assets}

(%)

0.39

3.32

4.72

 

 

 

 

 

Return on Investment (ROI)
(PBT/Networth)

 

0.01

0.10

0.12

 

 

 

 

 

Debt Equity Ratio
(Total Debt /Networth)

 

0.90

1.02

0.53

 

 

 

 

 

Current Ratio
(Current Asset/Current Liability)

 

1.09

1.16

1.09

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

10.150

10.150

19.756

Reserves & Surplus

19.340

22.278

22.438

Net worth

29.490

32.428

42.194

 

 

 

 

long-term borrowings

2.645

9.581

6.565

Short term borrowings

15.023

34.595

32.432

Total borrowings

17.668

44.176

38.997

Debt/Equity ratio

0.599

1.362

0.924

 

 

 

 

YEAR ON YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Sales

83.588

183.778

163.464

 

 

119.862

(11.054)

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(INR)

(INR)

(INR)

Sales

83.588

183.778

163.464

Profit

2.579

2.938

0.160

 

3.09%

1.60%

0.10%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S. No

Charge ID

Date of Charge Creation /Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN

1

10249474

21/10/2010

300,000.00

CANARA BANK

RETAIL ASSET HUB.CO., HYDERABAD, ANDHRA PRADESH - 500072, INDIA

A98592751

2

90128291

23/05/2003 *

300,000.00

CANARA BANK

SPECIALICED SSI BRANCH, KUTATPALLY, HYDERABAD, ANDHRA PRADESH, INDIA

-

3

90128215

02/06/2014 *

56,000,000.00

CANARA BANK

SME BRANCH, PLOT NO.74, PRASHANTHI NAGAR, KUKATPA LLY, HYDERABAD, TELANGANA - 500072, INDIA

C06413454

* Date of charge modification

 

 

OPERATIONS

 

The company turnover has reduced marginally due to inconsistence of power supply and recession in the industry and competition in the pharmacy market. The company is focused on ready to fill sustained release pellets in capsules and supplying to top 10 clients in India and exporting to many cities abroad. Now the company is diversifying in to finished dosage form of generic and ethical. The company has also upgraded its existing facility to WHO GMP standards located near Annaram Villge, Medak Dist, A.P. they have also started Spansules Research center which will Boost the sales by delivering the New Products in to the Market.

 

 

FIXED ASSETS

 

·         Land

·         Furniture and Fixtures

·         Plant and Machinery

·         Computers

·         Buildings

·         Electrical Equipment

·         Office Equipment

·         Motor Car

·         Vehicle - Splendor

·         Air Conditioner

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.81

UK Pound

1

Rs. 100.06

Euro

1

Rs. 78.47

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

NKT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

32

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.